Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-01

Clinical Trial Update: A Study To Evaluate The Efficacy And Safety Of Varenicline Compared To Placebo For Smoking Cessation Through Reduction [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing varenicline to placebo for smoking cessation via reduction, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2014-09-01